Patent · US Active

Modulators of dopamine neurotransmission

US8492372B2 · kind B2 · utility

0Cited by
15References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2009
Grant dateJul 23, 2013
Priority date
Expiry dateNov 8, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel 1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically asdopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.